Concepedia
Statistics
Publications
35
Citations
2.7K
H-Index
25
Active since
1976
Affiliations
Eli Lilly (United States)(Current)
National Institute on Drug Abuse
Novo Nordisk (Denmark)
H E Shannon is an author at Eli Lilly (United States) specializing in neuropharmacology, medicine, and pharmacology.
Publications per year
1976–2005
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
N. Bodick, Walter Offen, Allan I. Levey et al. · Archives of Neurology · 1997 · 685 citations
Medicine, Neurology, Pharmacology +17
Evaluation of the discriminative effects of morphine in the rat.
H E Shannon, S G Holtzman · Journal of Pharmacology and Experimental Therapeutics · 1976 · 191 citations
Medicine, Pharmacology, Behavioral Pharmacology +14
Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Frank P. Bymaster, Ian Heath, James Hendrix et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 138 citations
Medicine, Neuroscience, Pharmacology +16
Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat.
H E Shannon · Journal of Pharmacology and Experimental Therapeutics · 1981 · 123 citations
Medicine, Medicinal Chemistry, Pharmacology +11
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.
N. Bodick, Walter Offen, H E Shannon et al. · PubMed · 1997 · 116 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 35